Internal Medicine, Medical Oncology · New York, NY
NPI
1831327212
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
426 services
Medicare patients, 2024
199
Average age 72
Drug cost, 2024
$2.7M
297 prescriptions
Company payments, 2024
$246
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Carlo was code 99214 (office e&m - established), 122 times for 32 patients. In total Maria Carlo billed 426 services in 13 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 122 | 32 | $85.29 | $10K |
| 99203 Office E&M - New | Office | 96 | 96 | $87.24 | $8,375 |
| 99233 Hospital E&M - Subsequent | Facility | 70 | 19 | $102.80 | $7,196 |
| 99213 Office E&M - Established | Office | 65 | 46 | $60.82 | $3,953 |
By year: 2022 $41K for 486 services; 2023 $26K for 355 services; 2024 $36K for 426 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria Carlo prescribed most often to Medicare patients was Lenvima (Lenvatinib Mesylate), with 58 prescriptions and refills. In total Maria Carlo wrote 297 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenvima Lenvatinib Mesylate | 58 | 58 | Under 11 | $1.3M |
| Cabometyx Cabozantinib S-Malate | 51 | 51 | Under 11 | $767K |
| Amlodipine Besylate Generic | 36 | 56 | Under 11 | $332 |
| Levothyroxine Sodium Generic | 29 | 43 | Under 11 | $195 |
| Inlyta Axitinib | 24 | 24 | Under 11 | $399K |
| Clobetasol Propionate Generic | 12 | 14 | Under 11 | $802 |
Brand drugs: 149 claims; generic drugs: 148 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maria Carlo $246 ($246 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exelixis Inc. with $146.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 1 | $146 |
| Aveo Pharmaceuticals, Inc. | 1 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.